Cumberland Pharmaceuticals Inc. (CPIX)

Cumberland Pharmaceuticals Inc. Aktie (CPIX) Neueste Nachrichten

Earnings call: Cumberland Pharmaceuticals highlights steady Q1 demand - Investing.com Nigeria

Investing.com Nigeria

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2024 Earnings Call Transcript - Yahoo Canada Finance

Yahoo Canada Finance

Is Cumberland Pharmaceuticals (NASDAQ:CPIX) A Risky Investment? - Yahoo Canada Shine On

Yahoo Canada Shine On

Cumberland Pharmaceuticals Inc. 2024 Q1 - Results - Earnings Call Presentation (NASDAQ:CPIX) - Seeking Alpha

Seeking Alpha

Cumberland Pharmaceuticals (NASDAQ:CPIX) Receives New Coverage from Analysts at StockNews.com - Defense World

Defense World

Cumberland Pharmaceuticals First Quarter 2024 Earnings: US$0.14 loss per share (vs US$0.013 profit in 1Q 2023) - Yahoo Finance

Yahoo Finance

Cumberland: Q1 Earnings Snapshot - Houston Chronicle

Houston Chronicle

Cumberland: Q1 Earnings Snapshot | Business & Finance | citizentribune.com - Citizentribune

Citizentribune

Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update - PR Newswire

PR Newswire

StockNews.com Begins Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX) - Defense World

Defense World

Poisoning Treatment Market Revenue and Size Outlook | Cumberland Pharmaceuticals, Pfizer, BTG, Novartis - Amoré

Amoré

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Cumberland Pharmaceuticals Reports Annual 2023 Financial Results - PR Newswire

PR Newswire

Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results - PR Newswire

PR Newswire

Asthma Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight | Key Companies to Look Out ... - PR Newswire

PR Newswire

Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023 - PR Newswire

PR Newswire

Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis ... - PR Newswire

PR Newswire

Cumberland to launch Phase II trial of ifetroban for IPF - Clinical Trials Arena

Clinical Trials Arena

CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR NEW TREATMENT OF ... - PR Newswire

PR Newswire

CALDOLOR® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN INFANTS - PR Newswire

PR Newswire

Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company Update - PR Newswire

PR Newswire

CUMBERLAND PHARMACEUTICALS REPORTS 17% REVENUE GROWTH FOR FULL YEAR 2022 - PR Newswire

PR Newswire

Health care leader Joey Jacobs dies at 69 | Health Care | nashvillepost.com - Nashville Post

Nashville Post

CUMBERLAND PHARMACEUTICALS MOVES INTO NEW HEADQUARTERS AT BROADWEST - PR Newswire

PR Newswire

CUMBERLAND PHARMACEUTICALS APPOINTS MARTIN BROWN JR. TO ITS BOARD OF DIRECTORS - PR Newswire

PR Newswire

Change Healthcare brings lawsuit against former employee | Health Care | nashvillepost.com - Nashville Post

Nashville Post

Cumberland Pharmaceuticals Announces Key Co-Promotion Agreement with Verity Pharmaceuticals to Expand ... - PR Newswire

PR Newswire

TABUK AND CUMBERLAND PARTNER TO BRING INNOVATIVE ANTIBIOTIC WITH LIFE-SAVING POTENTIAL TO ... - PR Newswire

PR Newswire

CUMBERLAND PHARMACEUTICALS ACQUIRES SANCUSO® FROM KYOWA KIRIN NORTH AMERICA - PR Newswire

PR Newswire

Cumberland Pharmaceuticals Names John Hamm New Chief Financial Officer - PR Newswire

PR Newswire

Introducing RediTrex®, A New Methotrexate Delivery System - PR Newswire

PR Newswire

Cumberland Pharmaceuticals Announces The National Launch Of A New Caldolor Ready-To-Use Product - PR Newswire

PR Newswire

FDA approves Cumberland's methotrexate products line - Pharmaceutical Technology

Pharmaceutical Technology

NYSE Chief Operating Officer John Tuttle speaks at the Cumberland Pharma Foundation’s NYSE in Nashville luncheon - The Business Journals

The Business Journals

Cumberland Pharmaceuticals Announces Strategic Review - PR Newswire

PR Newswire

The Boss: Cumberland Pharmaceuticals' A.J. Kazimi - Nashville Business Journal - The Business Journals

The Business Journals

Cumberland paying $25M+ for antibiotic | | nashvillepost.com - Nashville Post

Nashville Post

Cumberland Pharmaceuticals Inc. Trade Ideas — NASDAQ:CPIX — TradingView - TradingView

TradingView

Cumberland Pharmaceuticals Expands into Oncology Support | Markets Insider - Markets Insider

Markets Insider

Cumberland Pharmaceuticals CEO AJ Kazimi talks about his company's growth strategy - The Business Journals

The Business Journals

New Kristalose® Growth Driver Established Through Co-Promotion Agreement - PR Newswire

PR Newswire

Derivation requires showing conception and communication of idea from claimed invention, not an obvious variant ... - IPWatchdog.com

IPWatchdog.com

Aurobindo Pharma gets USFDA nod for antidote to analgesic overdose - The Economic Times

The Economic Times